Analysis of the rationality of proton pump inhibitors in the prevention of stress ulcers in the perioperative period in general surgery areas
ZHAO Jing1 LI Lin-na2
1. Department of Pharmacy, Sihong County People′s Hospital, Suqian City, Jiangsu Province, Sihong 223900, China;
2. Department of Pharmacy, Jiangyin People′s Hospital, Jiangsu Province, Jiangyin 214400, China
Abstract:Objective To analyze the rationality of proton pump inhibitors (PPIs) in the prevention of stress ulcers (SU)in general surgery areas. Methods The clinical data of 264 patients who used PPIs during the perioperative period in the general surgery area of Sihong County People′s Hospital in August 2020 were retrospectively selected, and the disease severity, basic patient information, surgical status, and PPIs use status were screened according to the selection criteria. The rationality of PPIs medication were comprehensively evaluate. Results Among the 128 selected PPIs medical records, 4 types of PPIs were mainly involved, including omeprazole (injection), esomeprazole (injection), rabeprazole (injection), pantoprazole (injection). A total of 128 cases of preventive use of PPIs during the perioperative period were screened. There were 61 cases of irrational use of drugs, accounting for 47.66%, of which 16 cases (26.23%) were problematic in the route of medication, 32 cases (52.46%) were used without indications, and the course of medication was used. 8 cases (13.11%) were too long, 2 cases (3.28%) were incorrect in usage and dosage, and 3 cases (4.92%)had drug interactions. Conclusion When PPIs were used to prevent SU in this ward, there are unindicated medications,unsuitable selection of varieties and routes of administration, and unreasonable treatments. Relevant departments of the hospital should attach great importance to standardizing the rational use of PPIs.
赵晶;李琳娜. 普外病区围手术期应用质子泵抑制剂预防应激性溃疡的合理性分析[J]. 中国当代医药, 2021, 28(28): 157-159.
ZHAO Jing;LI Lin-na. Analysis of the rationality of proton pump inhibitors in the prevention of stress ulcers in the perioperative period in general surgery areas. 中国当代医药, 2021, 28(28): 157-159.
Vernaz N,Rollason V,Adlere L,et al.Snapshot of the prescribing practice for the clopidogrel and esomeprazole coprescription and cost evaluation of the application guidelines[J].Pharmacol Res Perspect,2016,4(3):e234.